I 
115TH CONGRESS 
2D SESSION 
H. R. 5925 
To codify provisions relating to the Office of National Drug Control, and 
for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 23, 2018 
Mr. GOWDY (for himself, Mr. CUMMINGS, Mr. MEADOWS, and Mr. CONNOLLY) 
introduced the following bill; which was referred to the Committee on 
Oversight and Government Reform, and in addition to the Committees 
on Energy and Commerce, Foreign Affairs, the Judiciary, Intelligence 
(Permanent Select), and Appropriations, for a period to be subsequently 
determined by the Speaker, in each case for consideration of such provi-
sions as fall within the jurisdiction of the committee concerned 
A BILL 
To codify provisions relating to the Office of National Drug 
Control, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Coordinated Response 
through Interagency Strategy and Information Sharing 
Act’’ or the ‘‘CRISIS Act’’. 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
SEC. 2. OFFICE OF NATIONAL DRUG CONTROL. 
(a) REDESIGNATION.—The Office of National Drug 
Control Policy shall be known as the ‘‘Office of National 
Drug Control’’. 
(b) REFERENCES.—Any reference in any other Fed-
eral law, Executive order, rule, regulation, or delegation 
of authority, or any document of or relating to the Office 
of National Drug Control Policy is deemed to refer to the 
Office of National Drug Control. 
(c) CODIFICATION.—Subtitle I of title 31, United 
States Code, is amended by adding at the end the fol-
lowing new chapter: 
‘‘CHAPTER 10—OFFICE OF NATIONAL 
DRUG CONTROL 
‘‘SUBCHAPTER I—OFFICE 
‘‘1001. Definitions. 
‘‘1002. Office of National Drug Control. 
‘‘1003. Administration of the office. 
‘‘1004. National drug control program budget. 
‘‘1005. National drug control strategy. 
‘‘1006. Development of an annual national drug control assessment. 
‘‘1007. Monitoring and evaluation of national drug control program. 
‘‘1008. Coordination and oversight of the national drug control program. 
‘‘1009. Emerging threats taskforce, plan, media campaign. 
‘‘1010. National and international coordination. 
‘‘1011. Interdiction. 
‘‘1012. Treatment coordinator. 
‘‘1013. Critical information coordination. 
‘‘1014. Authorization of appropriations. 
‘‘SUBCHAPTER II—HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM 
‘‘1021. High intensity drug trafficking areas program. 
‘‘SUBCHAPTER III—DRUG-FREE COMMUNITIES SUPPORT PROGRAM 
‘‘1031. Establishment of drug-free communities support program. 
‘‘1032. Program authorization. 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6211
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘1033. Information collection and dissemination with respect to grant recipi-
ents. 
‘‘1034. Technical assistance and training. 
‘‘1035. Supplemental grants for coalition mentoring activities. 
‘‘1036. Authorization for National Community Antidrug Coalition Institute. 
‘‘1037. Definitions. 
‘‘1038. Drug–free communities reauthorization. 
‘‘SUBCHAPTER I—OFFICE 
‘‘§ 1001. Definitions 
‘‘In this chapter: 
‘‘(1) AGENCY.—The term ‘agency’ has the 
meaning given the term ‘executive agency’ in section 
102. 
‘‘(2) APPROPRIATE
CONGRESSIONAL
COMMIT-
TEES.—The term ‘appropriate congressional com-
mittees’ means— 
‘‘(A) the Committee on the Judiciary, the 
Committee on Appropriations, and the Caucus 
on International Narcotics Control of the Sen-
ate; and 
‘‘(B) the Committee on Oversight and Gov-
ernment Reform, the Committee on the Judici-
ary, and the Committee on Appropriations of 
the House of Representatives. 
‘‘(3) DEMAND REDUCTION.—The term ‘demand 
reduction’ means any activity conducted by a Na-
tional Drug Control Program Agency, other than an 
enforcement activity, that is intended to reduce or 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
prevent the use of drugs or support or provide treat-
ment and recovery efforts, including— 
‘‘(A) education about the dangers of illicit 
drug use; 
‘‘(B) services, programs, or strategies to 
prevent substance use disorder, including evi-
dence-based education campaigns, community- 
based prevention programs, opioid diversion, 
collection and disposal of unused prescription 
drugs, and services to at-risk populations to 
prevent or delay initial use of an illicit sub-
stance; 
‘‘(C) substance use disorder treatment; 
‘‘(D) illicit drug use research; 
‘‘(E) drug-free workplace programs; 
‘‘(F) drug testing, including the testing of 
employees; 
‘‘(G) interventions for illicit drug use and 
dependence; 
‘‘(H) expanding availability of access to 
health care services for the treatment of sub-
stance use disorders; 
‘‘(I) international drug control coordina-
tion and cooperation with respect to activities 
described in this paragraph; 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(J) pre- and post-arrest criminal justice 
interventions such as diversion programs, drug 
courts, and the provision of evidence-based 
treatment to individuals with substance use dis-
orders who are arrested or under some form of 
criminal justice supervision, including medica-
tion assisted treatment; 
‘‘(K) other coordinated and joint initiatives 
among Federal, State, local, and Tribal agen-
cies to promote comprehensive drug control 
strategies designed to reduce the demand for, 
and the availability of, illegal drugs; 
‘‘(L) international illicit drug use edu-
cation, prevention, treatment, recovery, re-
search, rehabilitation activities, and interven-
tions for illicit drug use and dependence; and 
‘‘(M) research related to any of the activi-
ties described in this paragraph. 
‘‘(4) DIRECTOR.—The term ‘Director’ means 
the Director of the Office of National Drug Control. 
‘‘(5) DRUG.—The term ‘drug’ has the meaning 
given the term ‘controlled substance’ in section 
102(6) of the Controlled Substances Act (21 U.S.C. 
802(6)). 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(6) DRUG CONTROL.—The term ‘drug control’ 
means any activity conducted by a National Drug 
Control Program Agency involving supply reduction 
or demand reduction. 
‘‘(7) EMERGING THREAT.—The term ‘emerging 
threat’ means the occurrence of a new and growing 
trend in the use of an illicit drug or class of drugs, 
including rapid expansion in the supply of or de-
mand for such drug. 
‘‘(8) ILLICIT DRUG USE; ILLICIT DRUGS; ILLE-
GAL
DRUGS.—The terms ‘illicit drug use’, ‘illicit 
drugs’, and ‘illegal drugs’ include the illegal or illicit 
use of prescription drugs. 
‘‘(9) LAW ENFORCEMENT.—The term ‘law en-
forcement’ or ‘drug law enforcement’ means all ef-
forts by a Federal, State, local, or Tribal govern-
ment agency to enforce the drug laws of the United 
States or any State, including investigation, arrest, 
prosecution, and incarceration or other punishments 
or penalties. 
‘‘(10) NATIONAL DRUG CONTROL PROGRAM.— 
The term ‘National Drug Control Program’ means 
programs, policies, and activities undertaken by Na-
tional Drug Control Program Agencies pursuant to 
the responsibilities of such agencies under the Na-
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
tional Drug Control Strategy, including any activi-
ties involving supply reduction, demand reduction, or 
State, local, and Tribal affairs. 
‘‘(11) NATIONAL
DRUG
CONTROL
PROGRAM 
AGENCY.—The term ‘National Drug Control Pro-
gram Agency’ means any agency (or bureau, office, 
independent agency, board, division, commission, 
subdivision, unit, or other component thereof) that is 
responsible for implementing any aspect of the Na-
tional Drug Control Strategy, including any agency 
that receives Federal funds to implement any aspect 
of the National Drug Control Strategy, but does not 
include any agency that receives funds for drug con-
trol activity solely under the National Intelligence 
Program or the Military Intelligence Program. 
‘‘(12) NATIONAL
DRUG
CONTROL
STRATEGY; 
STRATEGY.—The term ‘National Drug Control 
Strategy’ or ‘Strategy’ means the strategy developed 
and submitted to Congress under section 1005. 
‘‘(13) NONPROFIT
ORGANIZATION.—The term 
‘nonprofit organization’ means an organization that 
is described in section 501(c)(3) of the Internal Rev-
enue Code of 1986 and exempt from tax under sec-
tion 501(a) of such Code. 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(14) OFFICE.—The term ‘Office’ means the 
Office of National Drug Control. 
‘‘(15) STATE, LOCAL, AND TRIBAL AFFAIRS.— 
The term ‘State, local, and Tribal affairs’ means do-
mestic activities conducted by a National Drug Con-
trol Program Agency that are intended to reduce the 
availability and use of illegal drugs, including— 
‘‘(A) coordination and enhancement of 
Federal, State, local, and Tribal law enforce-
ment drug control efforts; 
‘‘(B) coordination and enhancement of ef-
forts among National Drug Control Program 
Agencies and State, local, and Tribal demand 
reduction and supply reduction agencies; 
‘‘(C) coordination and enhancement of 
Federal, State, local, and Tribal law enforce-
ment initiatives to gather, analyze, and dissemi-
nate information and law enforcement intel-
ligence relating to drug control among domestic 
law enforcement agencies; and 
‘‘(D) other coordinated and joint initiatives 
among Federal, State, local, and Tribal agen-
cies to promote comprehensive drug control 
strategies designed to reduce the demand for, 
and the availability of, illegal drugs. 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(16) SUBSTANCE
USE
DISORDER
TREAT-
MENT.—The term ‘substance use disorder treat-
ment’ means an evidence-based, professionally di-
rected, deliberate, and planned regimen including 
evaluation, observation, medical monitoring, and re-
habilitative services and interventions such as 
pharmacotherapy, behavioral therapy, and individual 
and group counseling, on an inpatient or outpatient 
basis, to help patients with substance use disorder 
reach recovery. 
‘‘(17) SUPPLY REDUCTION.—The term ‘supply 
reduction’ means any activity or program conducted 
by a National Drug Control Program Agency that is 
intended to reduce the availability or use of illegal 
drugs in the United States or abroad, including— 
‘‘(A) law enforcement outside the United 
States; 
‘‘(B) domestic law enforcement; 
‘‘(C) source country programs, including 
economic development programs primarily in-
tended to reduce the production or trafficking 
of illicit drugs; 
‘‘(D) activities to control international traf-
ficking in, and availability of, illegal drugs, in-
cluding— 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(i) accurate assessment and moni-
toring of international drug production and 
interdiction programs and policies; and 
‘‘(ii) coordination and promotion of 
compliance with international treaties re-
lating to the production, transportation, or 
interdiction of illegal drugs; 
‘‘(E) activities to conduct and promote 
international law enforcement programs and 
policies to reduce the supply of drugs; 
‘‘(F) activities to facilitate and enhance the 
sharing of domestic and foreign intelligence in-
formation among National Drug Control Pro-
gram Agencies, relating to the production and 
trafficking of drugs in the United States and in 
foreign countries; 
‘‘(G) activities to prevent the diversion of 
drugs for their illicit use; and 
‘‘(H) research related to any of the activi-
ties described in this paragraph. 
‘‘§ 1002. Office of National Drug Control 
‘‘(a) ESTABLISHMENT OF OFFICE.—There is estab-
lished in the Executive Office of the President an Office 
of National Drug Control, which shall— 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(1) lead national drug control efforts, includ-
ing developing and assessing implementation of evi-
dence-based drug control policy; 
‘‘(2) coordinate and oversee the implementation 
of the national drug control policy, including the Na-
tional Drug Control Strategy; 
‘‘(3) assess and certify the adequacy of Na-
tional Drug Control Programs and the budget for 
those programs; 
‘‘(4) monitor and evaluate the effectiveness of 
national drug control policy efforts, including the 
National Drug Control Program Agencies’ pro-
grams, by developing and applying specific goals and 
performance measurements and tracking program- 
level spending; 
‘‘(5) identify and respond to emerging threats 
related to illicit drug use; 
‘‘(6) administer and evaluate grant programs in 
furtherance of the National Drug Control Strategy; 
and 
‘‘(7) facilitate broad-scale information sharing 
and data standardization among Federal, State, and 
local entities to support the national drug control ef-
forts. 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(b) DIRECTOR OF NATIONAL DRUG CONTROL AND 
DEPUTY DIRECTORS.— 
‘‘(1) DIRECTOR.— 
‘‘(A) IN GENERAL.—There shall be at the 
head of the Office a Director who shall hold the 
same rank and status as the head of an execu-
tive department listed in section 101 of title 5, 
United States Code. 
‘‘(B) APPOINTMENT.—The Director shall 
be appointed by the President, by and with the 
advice and consent of the Senate, and shall 
serve at the pleasure of the President. 
‘‘(2) DEPUTY DIRECTOR.— 
‘‘(A) IN GENERAL.—There shall be a Dep-
uty Director who shall report directly to the Di-
rector, be appointed by the President, and serve 
at the pleasure of the President. 
‘‘(B) RESPONSIBILITIES.—The Deputy Di-
rector shall— 
‘‘(i) carry out the responsibilities dele-
gated by the Director; and 
‘‘(ii) be responsible for effectively co-
ordinating with the Coordinators. 
‘‘(c) RESPONSIBILITIES.— 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(1) POLICIES, GOALS, OBJECTIVES, AND PRI-
ORITIES.—The Director shall assist the President in 
directing national drug control efforts, including es-
tablishing policies, goals, objectives, and priorities 
for the National Drug Control Program that are 
based on evidence-based research. 
‘‘(2) CONSULTATION.—To formulate the Na-
tional Drug Control policies, goals, objectives, and 
priorities, the Director— 
‘‘(A) shall consult with— 
‘‘(i) State and local governments; 
‘‘(ii) National Drug Control Program 
Agencies; 
‘‘(iii) each committee, working group, 
council, or other entity established under 
this chapter, as appropriate; 
‘‘(iv) the public; 
‘‘(v) appropriate congressional com-
mittees; and 
‘‘(vi) any other person in the discre-
tion of the Director; and 
‘‘(B) may— 
‘‘(i) establish advisory councils; 
‘‘(ii) acquire data from agencies; and 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(iii) request data from any other en-
tity. 
‘‘§ 1003. Administration of the office 
‘‘(a) EMPLOYMENT.— 
‘‘(1) AUTHORITY OF THE DIRECTOR.—The Di-
rector may select, appoint, employ, and fix com-
pensation of such officers and employees of the Of-
fice as may be necessary to carry out the functions 
of the Office under this chapter. 
‘‘(2) PROHIBITIONS.— 
‘‘(A) GENERALLY.—No person shall serve 
as Director or Deputy Director while serving in 
any other position in the Federal Government. 
‘‘(B) PROHIBITION
ON
POLITICAL
CAM-
PAIGNING.—Any officer or employee of the Of-
fice who is appointed to that position by the 
President, by and with the advice and consent 
of the Senate, may not participate in Federal 
election campaign activities, except that such 
official is not prohibited by this paragraph from 
making contributions to individual candidates. 
‘‘(b) PROHIBITION ON THE USE OF FUNDS FOR PO-
LITICAL CAMPAIGNS OR BALLOT INITIATIVES.—No funds 
authorized under this chapter may be obligated for the 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
purpose of influencing any Federal, State, or local election 
or ballot initiative. 
‘‘(c) PERSONNEL DETAILED TO OFFICE.— 
‘‘(1) EVALUATIONS.—Notwithstanding any pro-
vision of chapter 43 of title 5, the Director shall per-
form the evaluation of the performance of any em-
ployee detailed to the Office for purposes of the ap-
plicable performance appraisal system established 
under such chapter for any rating period, or part 
thereof, that such employee is detailed to such office. 
‘‘(2) COMPENSATION.— 
‘‘(A) BONUS PAYMENTS.—Subject to the 
availability of appropriations, the Director may 
provide periodic bonus payments to any em-
ployee detailed to the Office. 
‘‘(B) RESTRICTIONS.—An amount paid 
under this paragraph to an employee for any 
period— 
‘‘(i) shall not be greater than 20 per-
cent of the basic pay paid or payable to 
such employee for such period; and 
‘‘(ii) shall be in addition to the basic 
pay of such employee. 
‘‘(C) AGGREGATE
AMOUNT.—The aggre-
gate amount paid during any fiscal year to an 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
employee detailed to the Office as basic pay, 
awards, bonuses, and other compensation shall 
not exceed the annual rate payable at the end 
of such fiscal year for positions at level III of 
the Executive Schedule. 
‘‘(d) CONGRESSIONAL ACCESS TO INFORMATION.— 
The location of the Office in the Executive Office of the 
President shall not be construed as affecting access by 
Congress, or any committee of the House of Representa-
tives or the Senate, to any— 
‘‘(1) information, document, or study in the 
possession of, or conducted by or at the direction of 
the Director; or 
‘‘(2) personnel of the Office. 
‘‘(e) OTHER AUTHORITIES OF THE DIRECTOR.—In 
carrying out this chapter, the Director may— 
‘‘(1) use for administrative purposes, on a reim-
bursable basis, the available services, equipment, 
personnel, and facilities of Federal, State, and local 
agencies; 
‘‘(2) procure the services of experts and con-
sultants in accordance with section 3109 of title 5 
relating to appointments in the Federal Service, at 
rates of compensation for individuals not to exceed 
the daily equivalent of the rate of pay payable under 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
level IV of the Executive Schedule under section 
5311 of such title; and 
‘‘(3) use the mails in the same manner as any 
other agency. 
‘‘(f) GENERAL SERVICES ADMINISTRATION.—The 
Administrator of General Services shall provide to the Di-
rector, on a reimbursable basis, such administrative sup-
port services as the Director may request. 
‘‘§ 1004. National drug control program budget 
‘‘(a) BUDGET RECOMMENDATIONS.—Not later than 
July 1 of each year, the Director shall provide to the head 
of each National Drug Control Program Agency budget 
recommendations, including requests for specific initia-
tives that are consistent with the priorities of the Presi-
dent under the National Drug Control Strategy, which 
shall— 
‘‘(1) apply to the budget for the next fiscal year 
scheduled for formulation under chapter 11, and 
each of the 4 subsequent fiscal years; and 
‘‘(2) address funding priorities developed in the 
National Drug Control Strategy. 
‘‘(b) RESPONSIBILITIES OF NATIONAL DRUG CON-
TROL PROGRAM AGENCIES.— 
‘‘(1) IN GENERAL.—For each fiscal year, the 
head of each National Drug Control Program Agen-
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
cy shall transmit to the Director a copy of the pro-
posed drug control budget request of such agency at 
the same time as that budget request is submitted 
to their superiors (and before submission to the Of-
fice of Management and Budget) in the preparation 
of the budget of the President submitted to Con-
gress under section 1105(a). 
‘‘(2) SUBMISSION OF DRUG CONTROL BUDGET 
REQUESTS.—The head of each National Drug Con-
trol Program Agency shall ensure timely develop-
ment and submission to the Director of each pro-
posed drug control budget request transmitted pur-
suant to this subsection, in such format as may be 
designated by the Director with the concurrence of 
the Director of the Office of Management and Budg-
et. 
‘‘(3) CONTENT OF DRUG CONTROL BUDGET RE-
QUESTS.—A drug control budget request submitted 
by the head of a National Drug Control Program 
Agency under this subsection shall include all re-
quests for funds for any drug control activity under-
taken by such agency, including demand reduction, 
supply reduction, and State, local, and Tribal af-
fairs, including any drug law enforcement activities. 
If an activity has both drug control and nondrug 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
control purposes or applications, such agency shall 
estimate by a documented calculation the total funds 
requested for that activity that would be used for 
drug control, and shall set forth in its request the 
basis and method for making the estimate. 
‘‘(c) REVIEW AND CERTIFICATION OF BUDGET RE-
QUESTS AND BUDGET SUBMISSIONS OF NATIONAL DRUG 
CONTROL PROGRAM AGENCIES.— 
‘‘(1) IN GENERAL.—The Director shall review 
each drug control budget request submitted to the 
Director under subsection (b). 
‘‘(2) REVIEW OF BUDGET REQUESTS.— 
‘‘(A) INADEQUATE REQUESTS.—If the Di-
rector concludes that a budget request sub-
mitted under subsection (b) is inadequate, in 
whole or in part, to implement the objectives of 
the National Drug Control Strategy with re-
spect to the agency or program at issue for the 
year for which the request is submitted, the Di-
rector shall submit to the head of the applicable 
National Drug Control Program Agency a writ-
ten description identifying the funding levels 
and specific initiatives that would, in the deter-
mination of the Director, make the request ade-
quate to implement those objectives. 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(B) ADEQUATE REQUESTS.—If the Direc-
tor concludes that a budget request submitted 
under subsection (b) is adequate to implement 
the objectives of the National Drug Control 
Strategy with respect to the agency or program 
at issue for the year for which the request is 
submitted, the Director shall submit to the 
head of the applicable National Drug Control 
Program Agency a written statement con-
firming the adequacy of the request. 
‘‘(C) RECORD.—The Director shall main-
tain a record of each description submitted 
under subparagraph (A) and each statement 
submitted under subparagraph (B). 
‘‘(3) SPECIFIC REQUESTS.—The Director shall 
not confirm the adequacy of any budget request that 
requests a level of funding that will not enable 
achievement of the goals of the National Drug Con-
trol Strategy, including— 
‘‘(A) requests funding for Federal law en-
forcement activities that do not adequately com-
pensate for transfers of drug enforcement re-
sources and personnel to law enforcement and 
investigation activities; 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(B) requests funding for law enforcement 
activities on the borders of the United States 
that do not adequately direct resources to drug 
interdiction and enforcement; 
‘‘(C) requests funding for drug treatment 
activities that do not provide adequate results 
and accountability measures; 
‘‘(D) requests funding for drug treatment 
activities that do not adequately support and 
enhance Federal drug treatment programs and 
capacity; and 
‘‘(E) requests funding for the operations 
and management of the Department of Home-
land Security that does not include a specific 
request for funds for the Office of Counter-
narcotics Enforcement to carry out its respon-
sibilities under section 878 of the Homeland Se-
curity Act of 2002 (6 U.S.C. 458). 
‘‘(4) AGENCY RESPONSE.— 
‘‘(A) IN GENERAL.—The head of a Na-
tional Drug Control Program Agency that re-
ceives a description under paragraph (2)(A) 
shall include the funding levels and initiatives 
described by the Director in the budget submis-
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
sion for that agency to the Office of Manage-
ment and Budget. 
‘‘(B) IMPACT STATEMENT.—The head of a 
National Drug Control Program Agency that 
has altered its budget submission under this 
paragraph shall include as an appendix to the 
budget submission for that agency to the Office 
of Management and Budget an impact state-
ment that summarizes— 
‘‘(i) the changes made to the budget 
under this paragraph; and 
‘‘(ii) the impact of those changes on 
the ability of that agency to perform its 
other responsibilities, including any impact 
on specific missions or programs of the 
agency. 
‘‘(C) CONGRESSIONAL
NOTIFICATION.— 
The head of a National Drug Control Program 
Agency shall submit a copy of any impact state-
ment under subparagraph (B) to the Senate, 
the House of Representatives, and the appro-
priate congressional committees, at the time the 
budget for that agency is submitted to Congress 
under section 1105(a). 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(5) CERTIFICATION
OF
BUDGET
SUBMIS-
SIONS.— 
‘‘(A) IN
GENERAL.—At the time a Na-
tional Drug Control Program Agency submits 
its budget request to the Office of Management 
and Budget, the head of the National Drug 
Control Program Agency shall submit a copy of 
the budget request to the Director. 
‘‘(B) REVIEW
AND
CERTIFICATION
OF 
SUBMISSIONS.—The Director shall review each 
budget submission submitted under subpara-
graph (A) and submit to the appropriate con-
gressional committees one of the following: 
‘‘(i) A written certification of the 
budget request for the agency indicating 
such request fully funds the National Drug 
Control Programs as necessary to achieve 
the goals of the National Drug Control 
Strategy, including a written statement ex-
plaining the basis for the determination 
that the budget provides sufficient re-
sources for the agency to achieve the goals 
of the Strategy. 
‘‘(ii) A written certification of the 
budget request for the agency indicating 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
such request partially funds the National 
Drug Control Programs as necessary to 
achieve the goals of the Strategy, including 
a written statement explaining the basis 
for the determination and identifying the 
level of funding sufficient to achieve the 
goals of the Strategy. 
‘‘(iii) A written decertification of the 
budget request for the agency indicating 
the Director is unable to determine wheth-
er such budget request for the agency fully 
funds or partially funds the National Drug 
Control Programs as necessary to achieve 
the goals of the National Drug Control 
Strategy, including a written statement 
identifying the additional information nec-
essary for the Director to make a deter-
mination on such budget and the level of 
funding sufficient to achieve the goals of 
the Strategy. 
‘‘(iv) A written decertification of the 
budget request for the agency indicating 
that such budget is insufficient to fund the 
National Drug Control Programs as nec-
essary to achieve the goals of the Strategy, 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00024
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
including a written statement explaining 
the basis for the determination that the 
budget is insufficient and identifying the 
level of funding sufficient to achieve the 
goals of the Strategy. 
‘‘(d) NATIONAL DRUG CONTROL PROGRAM BUDGET 
PROPOSAL.—For each fiscal year, following the trans-
mission of proposed drug control budget requests to the 
Director under subsection (b), the Director shall, in con-
sultation with the head of each National Drug Control 
Program Agency and the head of each major national or-
ganization that represents law enforcement officers, agen-
cies, or associations— 
‘‘(1) develop a consolidated National Drug Con-
trol Program budget proposal designed to implement 
the National Drug Control Strategy and to inform 
Congress and the public about the total amount pro-
posed to be spent on all supply reduction, demand 
reduction, State, local, and Tribal affairs, including 
any drug law enforcement, and other drug control 
activities by the Federal Government, which shall 
conform to the content requirements set forth in 
subsection (b)(3) and include— 
‘‘(A) for each National Drug Control Pro-
gram Agency, a list of whether the funding level 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00025
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
is full, partial, or insufficient to achieve the 
goals of the National Drug Control Strategy or 
whether the Director is unable to determine 
whether the budget request for the agency fully 
funds or partially funds the agency’s activities 
and contributions as necessary to achieve the 
goals of National Drug Control Strategy; 
‘‘(B) a statement describing the extent to 
which any budget of a National Drug Control 
Program Agency with less than full funding 
hinders progress on achieving the goals of the 
National Drug Control Strategy; and 
‘‘(C) alternative funding structures that 
could improve progress on achieving the goals 
of the National Drug Control Strategy; and 
‘‘(2) submit the consolidated budget proposal to 
the President and Congress. 
‘‘(e) BUDGET ESTIMATE OR REQUEST SUBMISSION 
TO CONGRESS.—Whenever the Director submits any 
budget estimate or request to the President or the Office 
of Management and Budget, the Director shall concur-
rently transmit copies of that estimate or request to the 
appropriate congressional committees. 
‘‘(f) REPROGRAMMING AND TRANSFER REQUESTS.— 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00026
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(1) IN GENERAL.—No National Drug Control 
Program Agency shall submit to Congress a re-
programming or transfer request with respect to any 
amount of appropriated funds in an amount exceed-
ing $1,000,000 that is included in the National 
Drug Control Program budget unless the request 
has been approved by the Director. If the Director 
has not responded to a request for reprogramming 
subject to this paragraph within 30 days after re-
ceiving notice of the request having been made, the 
request shall be deemed approved by the Director 
under this paragraph and forwarded to Congress. 
‘‘(2) APPEAL.—The head of any National Drug 
Control Program Agency may appeal to the Presi-
dent any disapproval by the Director of a re-
programming or transfer request under this sub-
section. 
‘‘§ 1005. National drug control strategy 
‘‘(a) IN GENERAL.— 
‘‘(1) STATEMENT
OF
DRUG
POLICY
PRIOR-
ITIES.—The Director shall release a statement of 
drug policy priorities in the calendar year of a Presi-
dential inauguration following the inauguration but 
not later than April 1. 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00027
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(2) NATIONAL
DRUG
CONTROL
STRATEGY 
SUBMITTED
BY
THE
PRESIDENT.—Not later than 
the first Monday in February following the year in 
which the term of the President commences, the 
President shall submit to Congress a National Drug 
Control Strategy. 
‘‘(b) DEVELOPMENT OF THE NATIONAL DRUG CON-
TROL STRATEGY.— 
‘‘(1) PROMULGATION.—The Director shall pro-
mulgate the National Drug Control Strategy, which 
shall set forth a comprehensive plan to reduce illicit 
drug use and the consequences of such illicit drug 
use in the United States by limiting the availability 
of and reducing the demand for illegal drugs and 
promoting prevention, early intervention, treatment, 
and recovery support for individuals with substance 
use disorders. 
‘‘(2) STATE
AND
LOCAL
COMMITMENT.—The 
Director shall seek the support and commitment of 
State, local, and Tribal officials in the formulation 
and implementation of the National Drug Control 
Strategy. 
‘‘(3) STRATEGY BASED ON EVIDENCE.—The Di-
rector shall ensure the National Drug Control Strat-
egy is based on the best available medical and sci-
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00028
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
entific evidence regarding the policies that are most 
effective in reducing the demand for and supply of 
illegal drugs. 
‘‘(4) PROCESS FOR DEVELOPMENT AND SUB-
MISSION OF NATIONAL DRUG CONTROL STRATEGY.— 
In developing and effectively implementing the Na-
tional Drug Control Strategy, the Director— 
‘‘(A) shall consult with— 
‘‘(i) the heads of the National Drug 
Control Program Agencies; 
‘‘(ii) the United States Interdiction 
Coordinator; 
‘‘(iii) the Interdiction Committee; 
‘‘(iv) the appropriate congressional 
committees and any other committee of ju-
risdiction; 
‘‘(v) State, local, and Tribal officials; 
‘‘(vi) private citizens and organiza-
tions, including community and faith-based 
organizations, with experience and exper-
tise in demand reduction; 
‘‘(vii) private citizens and organiza-
tions with experience and expertise in sup-
ply reduction; and 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00029
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(viii) appropriate representatives of 
foreign governments; and 
‘‘(B) in satisfying the requirements of sub-
paragraph (A), shall ensure, to the maximum 
extent possible, that State, local, and Tribal of-
ficials and relevant private organizations com-
mit to support and take steps to achieve the 
goals and objectives of the National Drug Con-
trol Strategy. 
‘‘(c) CONTENTS OF THE NATIONAL DRUG CONTROL 
STRATEGY.— 
‘‘(1) IN GENERAL.—The National Drug Control 
Strategy submitted under subsection (a)(2) shall in-
clude the following: 
‘‘(A) A description of the current preva-
lence of illicit drug use in the United States, in-
cluding both the availability of illicit drugs and 
the prevalence of substance use disorders, which 
shall include the following: 
‘‘(i) Such description for the previous 
three years for any drug identified as an 
emerging threat under section 1009 and 
any other illicit drug identified by the Di-
rector as having a significant impact on 
the prevalence of illicit drug use. 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00030
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(ii) A summary of the data and 
trends presented in the Drug Control Data 
Dashboard required under section 1013. 
‘‘(B) A mission statement detailing the 
major functions of the National Drug Control 
Program. 
‘‘(C) A list of comprehensive, research- 
based, long-range, quantifiable goals for reduc-
ing illicit drug use, including— 
‘‘(i) the percentage of the total flow of 
illicit drugs to be interdicted during the 
time period covered by the Strategy; and 
‘‘(ii) the number of individuals to re-
ceive treatment for substance use dis-
orders. 
‘‘(D) A description of how each goal listed 
in the National Drug Control Strategy will be 
achieved, including— 
‘‘(i) a list of relevant National Drug 
Control Program Agencies and each such 
agency’s related programs, activities, and 
available assets and the role of each such 
program, activity, and asset in achieving 
the goal; 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00031
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(ii) a list of relevant stakeholders 
and each such stakeholder’s role in achiev-
ing the goal; 
‘‘(iii) an estimate of Federal funding 
and other resources needed to achieve each 
goal; 
‘‘(iv) an identification of existing or 
new coordinating mechanisms needed to 
achieve the goal; and 
‘‘(v) a description of the Office’s role 
in facilitating the achievement of such 
goal. 
‘‘(E) For each year covered by the Strat-
egy, a performance evaluation plan for each 
goal listed in the National Drug Control Strat-
egy for each National Drug Control Program 
Agency, including— 
‘‘(i) specific performance measures for 
each National Drug Control Program 
Agency and each such agency’s related 
programs and activities; 
‘‘(ii) annual and quarterly objectives 
and targets for each performance measure; 
and 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00032
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(iii) an estimate of Federal funding 
and other resources needed to achieve each 
performance measure. 
‘‘(F) A list identifying existing data 
sources or a description of data collection need-
ed to evaluate performance, including a descrip-
tion of how the Director will obtain such data. 
‘‘(G) A list of anticipated challenges to 
achieving the National Drug Control Strategy 
goals and planned actions to address such chal-
lenges; 
‘‘(H) A description of how each goal was 
determined, including— 
‘‘(i) a description of each required 
consultation and how such consultation 
was incorporated; 
‘‘(ii) data, research, or other informa-
tion used to inform the decision; and 
‘‘(iii) a statement of whether the goal 
established in subparagraph (C)(i) will be 
adequate to disrupt drug trafficking orga-
nizations that supply the majority of for-
eign-sourced illicit drugs trafficked into the 
United States. 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00033
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(I) A 5-year projection for program and 
budget priorities. 
‘‘(J) A review of international, State, local, 
and private sector drug control activities to en-
sure that the United States pursues coordinated 
and effective drug control at all levels of gov-
ernment. 
‘‘(K) Such statistical data and information 
as the Director considers appropriate to dem-
onstrate and assess trends relating to illicit 
drug use, the effects and consequences of illicit 
drug use (including the effects on children), 
supply reduction, demand reduction, drug-re-
lated law enforcement, and the implementation 
of the National Drug Control Strategy. 
‘‘(2) ADDITIONAL STRATEGIES.— 
‘‘(A) IN GENERAL.—The Director shall in-
clude in the National Drug Control Strategy 
the additional strategies required under this 
paragraph and shall comply with the following: 
‘‘(i) Provide a copy of the additional 
strategies to the appropriate congressional 
committees and to the Committee on 
Armed Services and the Committee on 
Homeland Security of the House of Rep-
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00034
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
resentatives, and the Committee on Home-
land Security and Governmental Affairs 
and the Committee on Armed Services of 
the Senate. 
‘‘(ii) Issue the additional strategies in 
consultation with the head of each relevant 
National Drug Control Program Agency 
and any relevant official of a State, local 
or Tribal government, and the government 
of other countries. 
‘‘(iii) Not change any existing agency 
authority or construe any strategy de-
scribed under this paragraph to amend or 
modify any law governing interagency rela-
tionship but may include recommendations 
about changes to such authority or law. 
‘‘(iv) Present separately from the rest 
of any strategy described under this para-
graph any information classified under cri-
teria established by an Executive order, or 
whose public disclosure, as determined by 
the Director or the head of any relevant 
National Drug Control Program Agency, 
would be detrimental to the law enforce-
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00035
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
ment or national security activities of any 
Federal, State, local, or Tribal agency. 
‘‘(B) 
REQUIREMENT
FOR
SOUTHWEST 
BORDER COUNTERNARCOTICS.— 
‘‘(i) PURPOSES.—The Southwest Bor-
der Counternarcotics Strategy shall— 
‘‘(I) set forth the Government’s 
strategy for preventing the illegal traf-
ficking of drugs across the inter-
national border between the United 
States and Mexico, including through 
ports of entry and between ports of 
entry on that border; 
‘‘(II) state the specific roles and 
responsibilities of the relevant Na-
tional Drug Control Program Agen-
cies for implementing that strategy; 
and 
‘‘(III) identify the specific re-
sources required to enable the relevant 
National 
Drug 
Control 
Program 
Agencies to implement that strategy. 
‘‘(ii) SPECIFIC CONTENT RELATED TO 
DRUG
TUNNELS
BETWEEN
THE
UNITED 
STATES
AND
MEXICO.—The Southwest 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
Border Counternarcotics Strategy shall in-
clude— 
‘‘(I) a strategy to end the con-
struction and use of tunnels and sub-
terranean passages that cross the 
international 
border 
between 
the 
United States and Mexico for the pur-
pose of illegal trafficking of drugs 
across such border; and 
‘‘(II) recommendations for crimi-
nal penalties for persons who con-
struct or use such a tunnel or sub-
terranean passage for such a purpose. 
‘‘(C) REQUIREMENT FOR NORTHERN BOR-
DER COUNTERNARCOTICS STRATEGY.— 
‘‘(i) PURPOSES.—The Northern Bor-
der Counternarcotics Strategy shall— 
‘‘(I) set forth the strategy of the 
Federal Government for preventing 
the illegal trafficking of drugs across 
the international border between the 
United States and Canada, including 
through ports of entry and between 
ports of entry on the border; 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00037
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(II) state the specific roles and 
responsibilities of each relevant Na-
tional Drug Control Program Agency 
for implementing the strategy; 
‘‘(III) identify the specific re-
sources required to enable the relevant 
National 
Drug 
Control 
Program 
Agencies to implement the strategy; 
‘‘(IV) be designed to promote, 
and not hinder, legitimate trade and 
travel; and 
‘‘(V) reflect the unique nature of 
small communities along the inter-
national border between the United 
States and Canada, ongoing coopera-
tion and coordination with Canadian 
law, 
enforcement 
authorities, 
and 
variations in the volumes of vehicles 
and 
pedestrians 
crossing 
through 
ports of entry along the international 
border between the United States and 
Canada. 
‘‘(ii) SPECIFIC CONTENT RELATED TO 
CROSS-BORDER
INDIAN
RESERVATIONS.— 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00038
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
The Northern Border Counternarcotics 
Strategy shall include— 
‘‘(I) a strategy to end the illegal 
trafficking of drugs to or through In-
dian reservations on or near the inter-
national border between the United 
States and Canada; and 
‘‘(II) recommendations for addi-
tional assistance, if any, needed by 
Tribal law enforcement agencies relat-
ing to the strategy, including an eval-
uation of Federal technical and finan-
cial assistance, infrastructure capacity 
building, and interoperability defi-
ciencies. 
‘‘(3) CLASSIFIED INFORMATION.—Any contents 
of the National Drug Control Strategy that involve 
information properly classified under criteria estab-
lished by an Executive order shall be presented to 
Congress separately from the rest of the National 
Drug Control Strategy. 
‘‘(4) SELECTION
OF
DATA
AND
INFORMA-
TION.—In selecting data and information for inclu-
sion under paragraph (1), the Director shall en-
sure— 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00039
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(A) the inclusion of data and information 
that will permit analysis of current trends 
against previously compiled data and informa-
tion where the Director believes such analysis 
enhances long-term assessment of the National 
Drug Control Strategy; and 
‘‘(B) the inclusion of data and information 
to permit a standardized and uniform assess-
ment of the effectiveness of drug treatment pro-
grams in the United States. 
‘‘(d) ANNUAL PERFORMANCE SUPPLEMENT.—Not 
later than the first Monday in February of each year fol-
lowing the year in which the National Drug Control Strat-
egy is submitted pursuant to subsection (a)(2), the Direc-
tor shall submit to the appropriate congressional commit-
tees a supplement to the Strategy that shall include— 
‘‘(1) annual and quarterly quantifiable and 
measurable objectives and specific targets to accom-
plish long-term quantifiable goals specified in the 
Strategy; and 
‘‘(2) for each year covered by the Strategy, a 
performance evaluation plan for each goal listed in 
the Strategy for each National Drug Control Pro-
gram Agency, including— 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00040
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(A) specific performance measures for 
each National Drug Control Program Agency 
and each such agency’s related programs and 
activities; 
‘‘(B) annual and quarterly objectives and 
targets for each performance measure; and 
‘‘(C) an estimate of Federal funding and 
other resources needed to achieve each perform-
ance measure. 
‘‘(e) SUBMISSION
OF
REVISED
STRATEGY.—The 
President may submit to Congress a revised National 
Drug Control Strategy that meets the requirements of this 
section— 
‘‘(1) at any time, upon a determination of the 
President, in consultation with the Director, that the 
National Drug Control Strategy in effect is not suf-
ficiently effective; or 
‘‘(2) if a new President or Director takes office. 
‘‘§ 1006. Development of an annual national drug con-
trol assessment 
‘‘(a) TIMING.—Not later than the first Monday in 
February of each year, the Director shall submit to the 
President, Congress, and the appropriate congressional 
committees, a report assessing the progress of each Na-
tional Drug Control Program Agency toward achieving the 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00041
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
annual goals, objectives, and targets contained in the Na-
tional Drug Control Strategy applicable to the prior fiscal 
year. 
‘‘(b) PROCESS FOR DEVELOPMENT OF THE ANNUAL 
ASSESSMENT.—Not later than November 1 of each year, 
the head of each National Drug Control Program Agency 
shall submit, in accordance with guidance issued by the 
Director, to the Director an evaluation of progress by the 
agency with respect to drug control program goals using 
the performance measures for the agency developed under 
this section, including progress with respect to— 
‘‘(1) success in achieving the goals of the Na-
tional Drug Control Strategy; 
‘‘(2) success in reducing domestic and foreign 
sources of illegal drugs; 
‘‘(3) success in expanding access to and in-
creasing the effectiveness of substance use disorder 
treatment; 
‘‘(4) success in protecting the borders of the 
United States (and in particular the Southwestern 
border of the United States) from penetration by il-
legal narcotics; 
‘‘(5) success in reducing crime associated with 
drug use in the United States; 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00042
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(6) success in reducing the negative health 
and social consequences of drug use in the United 
States; and 
‘‘(7) implementation of drug treatment and pre-
vention programs in the United States and improve-
ments in the adequacy and effectiveness of such pro-
grams. 
‘‘(c) CONTENTS OF THE ANNUAL ASSESSMENT.— 
The Director shall include in the annual assessment re-
quired under subsection (a)— 
‘‘(1) a summary of each evaluation received by 
the Director under subsection (b); 
‘‘(2) a summary of the progress of each Na-
tional Drug Control Program Agency toward the 
drug control program goals of the agency using the 
performance measures for the agency developed 
under this section; 
‘‘(3) an assessment of the effectiveness of each 
Drug Control Program agency and program in 
achieving the National Drug Control Strategy for 
the previous year, including a specific evaluation of 
whether the applicable goals, measures, objectives, 
and targets for the previous year were met; 
‘‘(4) for National Drug Control Program Agen-
cies that administer grant programs, an evaluation 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00043
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
of the effectiveness of each grant program, including 
an accounting of the funds disbursed by the pro-
gram in the prior year and a summary of how those 
funds were used by the grantees and sub-grantees 
during that period; 
‘‘(5) a detailed accounting of the amount of 
funds obligated by each National Drug Control Pro-
gram Agency in carrying out the responsibilities of 
that agency under the Strategy, including the infor-
mation submitted to the Director under section 
1007(b); 
‘‘(6) an assessment of the effectiveness of any 
Emerging Threat Response Plan in effect for the 
previous year, including a specific evaluation of 
whether the objectives and targets were met and rea-
sons for the success or failure of the previous year’s 
plan; 
‘‘(7) a detailed accounting of the amount of 
funds obligated during the previous fiscal year for 
carrying out the media campaign under section 
1009(d), including each recipient of funds, the pur-
pose of each expenditure, the amount of each ex-
penditure, any available outcome information, and 
any other information necessary to provide a com-
plete accounting of the funds expended; and 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00044
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(8) the assessments required under this sub-
section shall be based on the Performance Measure-
ment System describe in subsection (d). 
‘‘(d) PERFORMANCE MEASUREMENT SYSTEM.—The 
Director shall include in the annual assessment required 
under subsection (a) a national drug control performance 
measurement system, that— 
‘‘(1) develops annual, 2-year, and 5-year per-
formance measures, objectives, and targets for each 
National Drug Control Strategy goal and objective 
established for reducing drug use, availability, and 
the consequences of drug use; 
‘‘(2) describes the sources of information and 
data that will be used for each performance measure 
incorporated into the performance measurement sys-
tem; 
‘‘(3) identifies major programs and activities of 
the National Drug Control Program Agencies that 
support the goals and annual objectives of the Na-
tional Drug Control Strategy; 
‘‘(4) evaluates the contribution of demand re-
duction and supply reduction activities implemented 
by each National Drug Control Program Agency in 
support of the National Drug Control Strategy; 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00045
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(5) monitors consistency between the drug-re-
lated goals, measures, targets, and objectives of the 
National Drug Control Program Agencies and en-
sures that each agency’s goals and budgets support, 
and are fully consistent with, the National Drug 
Control Strategy; and 
‘‘(6) coordinates the development and imple-
mentation of national drug control data collection 
and reporting systems to support policy formulation 
and performance measurement, including an assess-
ment of— 
‘‘(A) the quality of current drug use meas-
urement instruments and techniques to measure 
supply reduction and demand reduction activi-
ties; 
‘‘(B) the adequacy of the coverage of exist-
ing national drug use measurement instruments 
and techniques to measure the illicit drug user 
population, and groups that are at risk for il-
licit drug use; 
‘‘(C) the adequacy of the coverage of exist-
ing national treatment outcome monitoring sys-
tems to measure the effectiveness of substance 
use disorder treatment in reducing illicit drug 
use and criminal behavior during and after the 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00046
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
completion of substance use disorder treatment; 
and 
‘‘(D) the actions the Director shall take to 
correct any deficiencies and limitations identi-
fied pursuant to subparagraphs (A), (B), and 
(C). 
‘‘(e) MODIFICATIONS.—A description of any modi-
fications made during the preceding year to the national 
drug performance measurement system described in sub-
section (d) shall be included in each report submitted 
under subsection (a). 
‘‘(f) ANNUAL REPORT ON CONSULTATION.—The Di-
rector shall include in the annual assessment required 
under subsection (a)— 
‘‘(1) a detailed description of how the Office 
has consulted with and assisted State, local, and 
Tribal governments with respect to the formulation 
and implementation of the National Drug Control 
Strategy and other relevant issues; and 
‘‘(2) a general review of the status of, and 
trends in, demand reduction activities by private sec-
tor entities and community-based organizations, in-
cluding faith-based organizations, to determine their 
effectiveness and the extent of cooperation, coordina-
tion, and mutual support between such entities and 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00047
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
organizations and Federal, State, local, and Tribal 
government agencies. 
‘‘(g) PERFORMANCE-BUDGET COORDINATOR.— 
‘‘(1) DESIGNATION.—The Director shall des-
ignate or appoint a United States Performance- 
Budget Coordinator to— 
‘‘(A) ensure the Director has sufficient in-
formation about the performance of each Na-
tional Drug Control Program Agency, the im-
pact Federal funding has had on the goals in 
the Strategy, and the likely contributions to the 
goals of the Strategy based on funding levels of 
each National Drug Control Program Agency, 
to make an independent assessment of the 
budget request of each agency under section 
1004; 
‘‘(B) advise the Director on agency budg-
ets, performance measures and targets, and ad-
ditional data and research needed to make in-
formed policy decisions in the National Drug 
Control Budget and Strategy; and 
‘‘(C) other duties as may be determined by 
the Director with respect to measuring or as-
sessing performance or agency budgets. 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00048
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(2) DETERMINATION OF POSITION.—The Di-
rector shall determine whether the coordinator posi-
tion is a career or noncareer position in the Senior 
Executive Service. 
‘‘§ 1007. Monitoring and evaluation of national drug 
control program 
‘‘(a) IN GENERAL.—The Director shall monitor im-
plementation of the National Drug Control Program and 
the activities of the National Drug Control Program Agen-
cies in carrying out the goals and objectives of the Na-
tional Drug Control Strategy including— 
‘‘(1) conducting program and performance au-
dits and evaluations; and 
‘‘(2) requesting assistance from the Inspector 
General of the relevant agency in such audits and 
evaluations. 
‘‘(b) ACCOUNTING OF FUNDS EXPENDED.—Not later 
than December 1 of each year and in accordance with 
guidance issued by the Director, the head of each National 
Drug Control Program Agency shall submit to the Direc-
tor a detailed accounting of all funds expended by the 
agency for National Drug Control Program activities dur-
ing the previous fiscal year and shall ensure such detailed 
accounting is authenticated by the Inspector General for 
such agency prior to submission to the Director. 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00049
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
‘‘(c) NOTIFICATION.—The Director shall notify any 
National Drug Control Program Agency if its activities 
are not in compliance with the responsibilities of the agen-
cy under the National Drug Control Strategy, transmit 
a copy of each such notification to the President and the 
appropriate congressional committees, and maintain a 
copy of each such notification. 
‘‘(d) RECOMMENDATIONS.—The Director shall make 
such recommendations to the President and the appro-
priate congressional committees as the Director deter-
mines are appropriate regarding changes in the organiza-
tion, management, and budgets of the National Drug Con-
trol Program Agencies, and changes in the allocation of 
personnel to and within those agencies, to implement the 
policies, goals, priorities, and objectives established under 
section 1002(c)(1) and the National Drug Control Strat-
egy. 
‘‘§ 1008. Coordination and oversight of the national 
drug control program 
‘‘(a) IN GENERAL.—The Director shall coordinate 
and oversee the implementation by the National Drug 
Control Program Agencies of the policies, goals, objectives, 
and priorities established under section 1002(c)(1) and 
the fulfillment of the responsibilities of such agencies 
under the National Drug Control Strategy and make rec-
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00050
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS
ommendations to National Drug Control Program Agency 
heads with respect to implementation of National Drug 
Control Programs. 
‘‘(b) DETAILING EMPLOYEES
TO OTHER AGEN-
CIES.— 
‘‘(1) REQUEST.—The Director may request the 
head of an agency or program of the Federal Gov-
ernment to place agency personnel who are engaged 
in drug control activities on temporary detail to an-
other agency in order to implement the National 
Drug Control Strategy. 
‘‘(2) AGENCY COMPLIANCE.—The head of the 
agency shall comply with such a request. 
‘‘(3) MAXIMUM NUMBER OF DETAILEES.—The 
maximum number of personnel who may be detailed 
to another agency (including the Office) under this 
subsection during any fiscal year is— 
‘‘(A) for the Department of Defense, 50; 
and 
‘‘(B) for any other agency, 10. 
‘‘(c) DIRECTING FEDERAL FUNDING.—The Director 
may transfer funds made available to a National Drug 
Control Program Agency for National Drug Control Strat-
egy programs and activities to another account within 
such agency or to another National Drug Control Program 
VerDate Sep 11 2014 
22:44 May 24, 2018
Jkt 079200
PO 00000
Frm 00051
Fmt 6652
Sfmt 6201
E:\BILLS\H5925.IH
H5925
pbinns on DSK79D2C42PROD with BILLS